NCT02734966 - Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury | Biotech Hunter

Enrollment

174

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2011

Conditions

Drug-Induced Liver Injury

Interventions

DRUG

Magnesium Isoglycyrrhizinate Injection 100mg OD

DRUG

Magnesium Isoglycyrrhizinate Injection 200mg OD

Magnesium Isoglycyrrhizinate Injection 200mg OD for 4 weeks

DRUG

Tiopronin Injection

Tiopronin Injection 200mg OD

Trial Locations (8)

Beijing Chest Hospital, Capital Medical University, Beijing

Nanjing Pulmonary Hospital, Nanjing

85 Hospital of People's Liberation Army, Shanghai

Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai

Shanghai Pulmonary Hospital, Shanghai

Shanghai Sixth People's Hospital, Shanghai

Integrated Chinese and Western Medicine Hospital of Zhejiang Province, Hangzhou

Zhejiang Cancer Hospital, Hangzhou